(Q39388525)

11 September 2017

title

Estrogen receptor α attenuates therapeutic efficacy of paclitaxel on breast xenograft tumors (English)

1 reference

11 September 2017

1 reference

1 reference

Jinjia Chang

1

1 reference

11 September 2017

Meihua Sui

series ordinal

2

1 reference

11 September 2017

Weimin Fan

series ordinal

3

1 reference

11 September 2017

language of work or name

English

0 references

publication date

29 February 2012

1 reference

Breast Cancer Research and Treatment

11 September 2017

published in

1 reference

11 September 2017

volume

134

1 reference

11 September 2017

issue

3

1 reference

11 September 2017

page(s)

969-980

1 reference

Weekly paclitaxel: an effective and well-tolerated treatment in patients with advanced breast cancer

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-1994-8

Taxanes in the treatment of early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-1994-8

Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific beta-tubulin isotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-1994-8

Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-1994-8

Epigenetic regulation of the taxol resistance-associated gene TRAG-3 in human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-1994-8

Reversal of stathmin-mediated resistance to paclitaxel and vinblastine in human breast carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-1994-8

Estrogen-receptor-negative breast cancer tissue is chemosensitive in vitro compared with estrogen-receptor-positive tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-1994-8

Estrogen receptor alpha mediates breast cancer cell resistance to paclitaxel through inhibition of apoptotic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-1994-8

Glucocorticoids interfere with therapeutic efficacy of paclitaxel against human breast and ovarian xenograft tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-1994-8

Fulvestrant (ICI 182,780) sensitizes breast cancer cells expressing estrogen receptor alpha to vinblastine and vinorelbine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-1994-8

Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-1994-8

Glucocorticoids selectively inhibit paclitaxel-induced apoptosis: mechanisms and its clinical impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-1994-8

The human tumour cloning assay in the management of breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-1994-8

Subrenal capsule assay in human breast cancer. Response to cytostatic drug combinations and correlation with receptor status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-1994-8

Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-1994-8

Estrogen receptor expression and sensitivity to paclitaxel in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-1994-8

Faslodex (ICI 182, 780), a novel estrogen receptor downregulator--future possibilities in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-1994-8

Apoptosis. Its significance in cancer and cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-1994-8

Morphologic and biochemical hallmarks of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-1994-8

Immunohistochemical detection of Ki67 in breast cancer correlates with transcriptional regulation of genes related to apoptosis and cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-1994-8

Change in tumor cellularity of breast carcinoma after neoadjuvant chemotherapy as a variable in the pathologic assessment of response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-1994-8

Current research topics in endocrine therapy for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-1994-8

Utilizing prognostic and predictive factors in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-1994-8

Prediction of response to hormonal treatment in metastatic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-1994-8

The potential biomarkers in predicting pathologic response of breast cancer to three different chemotherapy regimens: a case control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-1994-8

Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-1994-8

The lack of relationship between estrogen receptor status and response to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-1994-8

Effect of the selective estrogen receptor modulator arzoxifene on repopulation of hormone-responsive breast cancer xenografts between courses of chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-1994-8

Effects of a combination of exemestane and paclitaxel on human tumor cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-1994-8

Response to primary chemotherapy in breast cancer patients with tumors not expressing estrogen and progesterone receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-1994-8

10.1007/S10549-012-1994-8

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference